Ken Griffin's position in Royalty Pharma plc is currently worth $13.6 Million. That's 0.01% of their equity portfolio (976th largest holding). The first Royalty Pharma plc trade was made in Q2 2020. Since then Ken Griffin bought shares eight more times and sold shares on five occasions. The investor's estimated purchase price is $19.9 Million, resulting in a loss of 31%.